Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 411-490-4 | CAS number: 7027-11-4 ISOPHORONENITRILE, IPN
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1991-02-04 to 1992-02-21
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 3-cyano-3,5,5-trimethylcyclohexanone
- EC Number:
- 411-490-4
- EC Name:
- 3-cyano-3,5,5-trimethylcyclohexanone
- Cas Number:
- 7027-11-4
- Molecular formula:
- C10H15NO
- IUPAC Name:
- 3-cyano-3,5,5-trimethylcyclohexanone
- Details on test material:
- Isophorone nitrile of Degussa AG. Batch No. 64-II/78/90. Purity 99.6 % (GC).
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ORGANISMS:
- Source: Winkelmann, Borchen (Germany)
- Age: 6 weeks
- Weight at study initiation: 25-33 g (males); 23-29 g (females)
- No. of animals per dose: 18 males + 18 females (control groups); 21 males + 21 females (test group)
- Housing: single in conventional Makrolon Typ II cages
- Diet: standard diet ssniff M, ad libitum
- Water: tab water ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/- 2 °C
- Humidity (%): approximately 55 +/- 15 %
- Photoperiod (hrs dark / hrs light): 12 h/ 12h
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle: Traganth (1 % suspension in water - aqua ad iniectabilia)
- Details on exposure:
- - Control groups and treatment:
negative: vehicle
positive: 51.1 mg cyclophosphamide (CPA)/kg bw in physiological NaCl solution (0.9 %)
- Total volume applied: 10 ml/kg bw
- Duration of test: 24 hours; 48 hours; 72 hours
- Clinical observations: First 4-6 hours after administration; once daily on days 2 and 3
- Sampling times and number of samples: 24 hours; 48 hours; 72 hours: 6 mice per sex and control group,
7 mice per sex of test group; normally first 5 per sex and group evaluated
- Organs examined at necropsy: femur bone marrow; gross necropsy on animals deceased intercurrently (no further details in report)
1000 PCE (polychromatic erythrocytes) per animal were analysed for micronuclei - Duration of treatment / exposure:
- single oral application
- Frequency of treatment:
- 1 time
- Post exposure period:
- 24h, 48 h, 72 h
Doses / concentrations
- Remarks:
- Doses / Concentrations:
82.5 mg/kg bw (males and females)
Basis:
nominal conc.
- No. of animals per sex per dose:
- 18 control groups; 21 test group
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamid (Endoxan) 51.4 mg/kg body weight in physiological saline solution by oral gavage
Examinations
- Tissues and cell types examined:
- polychromatic erythrocytes of the bone marrow from femur
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: maximum dose without mortalities
DETAILS OF SLIDE PREPARATION: Bone marrow from both femurs were flushed with 1.5 ml fetal calf serum, centrifuged, suspended upon a thin layer of serum and smeared on a slide. The smears were stained using the panoptic stain method developed by PAPPENHEIM. - Evaluation criteria:
- - Criteria for evaluating results: statistically significant (p<0.05) and reproducible increase in frequency of micronucleated polychromatic
erythrocytes of at least one test group sampling time as compared to the same sampling time of the negative control group - Statistics:
- BIOMETRY:
- Normally 1000 polychromatic erythrocytes were counted per animal.
-The frequencies of micronucleated polychromatic erythrocytes of the test material group and the positive control group were compared with those of the the negative control group at each sampling time.
-A POISSON test was applied, the data from each treatment group for each sex as well as for both sexes combines were compared with the respective negative conrol group data using a VAX 8200 computer. Values of 5 animals of each sex and sampling time were used for statistical evaluation.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- other: negative control=vehicle control
- Positive controls validity:
- valid
- Additional information on results:
- MORTALITY:
- Dose finding
100 mg/kg bw: Severe symptoms of toxicity and death.
82.5; 75.0; 68.1 mg/kg bw: Clear symptoms of toxicity, no death.
- Main test: 1 male from the test group died 9 minutes after administration.
CLINICAL SIGNS (test group): Slight to severe clonic convulsions in the test group (9/21 males, 6/21 females). No abnormal clinical signs in the
control groups.
NECROPSY FINDINGS: Main test: The male that died was necropsied: No abnormalities were detected.
EFFECT ON MITOTIC INDEX OR PCE/NCE RATIO: No reduction in PCE/NCE ratio was present in test material group animals when compared with
the corresponding negative control animals, with the exception of one male at the 24 hours sampling time.
The average PCE/NCE ratio of the positive control animals was significantly lower than that of the corresponding vehicle controls at 48 and
72 hours. Due to technical error in the preparation of the slides, realistic PCE/NCE ratios for 72 hour control males cannot be given
(accidental damage of NCE cell membranes, PCE unaffected).
GENOTOXIC EFFECTS: For the positive control a significant and clear increase in the frequency of micronucleated polychromatic erythrocytes
was observed (except females at 72 hours). Upon administration of the test substance, no significant increase over the corresponding
negative controls was observed in either male or female animals, as well as for both sexes combined, at any of the sampling times.
Any other information on results incl. tables
Summary of results
Treatment Sex Time Micron./1000 PCE PCE/NCE
--------------------------------------------------------
Test subst. m 24 h 2.2 +- 0.84 0.48 - 2.09
Vehicle m 24 h 1.8 +- 0.84 1.08 - 1.33
CPA m 24 h 35.6 +- 3.91 * 0.52 - 1.22
Test subst. f 24 h 1.2 +- 1.10 0.75 - 1.20
Vehicle f 24 h 1.4 +- 0.55 0.69 - 0.98
CPA f 24 h 23.6 +- 6.73 * 0.53 - 1.28
Test subst. m 48 h 2.0 +- 1.41 1.04 - 1.75
Vehicle m 48 h 0.8 +- 1.30 1.24 - 1.60
CPA m 48 h 9.6 +- 3.13 * 0.26 - 1.11 *
Test subst. f 48 h 2.0 +- 1.00 0.92 - 1.70
Vehicle f 48 h 2.0 +- 1.00 0.92 - 1.51
CPA f 48 h 5.0 +- 2.82 * 0.47 - 0.64 *
Test subst. m 72 h 1.4 +- 2.07 1.36 - 1.95
Vehicle m 72 h 1.0 +- 1.22 no data
CPA m 72 h 4.4 +- 2.88 * 0.13 - 0.57
Test subst. f 72 h 2.6 +- 1.82 1.07 - 1.86
Vehicle f 72 h 2.0 +- 1.73 0.73 - 1.65
CPA f 72 h 1.6 +- 1.14 0.20 - 0.43 *
--------------------------------------------------------
CPA = cyclophosphamide; * = statistical significance
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Isophorone nitrile is not a mutagenic substance under the in vivo conditions in this micronucleus assay using male and female NMRI mice. - Executive summary:
The results of this study indicate that under the test conditions, isophorone nitrile did not induce micronucleated polychromatic erythrocytes in male and female mice. 82.5 mg/kg bw isophorone nitrile was administered oral to 21 male and 21 female NMRI mice per group. This doses were selected as the maximum tolerated dose (MTD) based upon a preliminary toxicity study. Bone marrow polychromatic erythrocytes, collected from 5 male and female mice 24, 48 and 72 hours after single treatment, were examined microscopically for micronucleated polychromatic erythrocytes (PCE). No significant increase in the frequency of PCE over the control was found with any group treated with the test substance. For the positive control (cyclophosphamid, CPA) a significant increase in the frequency of PCE was observed. Therefore, isophorone nitrile is not a mutagenic substance under the in vivo conditions in this micronucleus assay using male and female NMRI mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.